News

Highmark and Independence Blue Cross (IBC) have submitted the applications to the Pennsylvania Insurance Department (PID) in April 2007. In a joint statement, Kenneth Melani, president and CEO

The site has a new purpose-built, 100-bed facility designed to run clinical pharmacology studies in healthy, diabetic and obese participants. Well-known for conducting first-in-human, proof-of-concept studies and participating

Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office. QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008. In

Pursuant to the terms of the agreement, Medline will serve as the group’s primary distributor providing medical and surgical products and services. The agreement will focus on driving

Ecard is a tablet taken orally once daily and the two approved formulations are ‘Ecard LD’ and ‘Ecard HD’; 4mg candesartan cilexetil/6.25mg hydrochlorothiazide and 8mg candesartan cilexetil/6.25mg hydrochlorothiazide,

Recalbon tablets 1mg or Bonoteo tablets 1mg (Minodronic acid hydrate) is an orally taken bisphosphonate that was first discovered in Japan and reportedly exhibits extremely potent inhibition of

The proposed transaction reflects Biovitrum’s previously announced decision to focus its in-house R&D on specialist pharmaceuticals and protein therapeutics. Biovitrum has engaged Nomura Code in this process. The

The combined company will also continue to operate its offices in Madrid, Spain providing drug development services to companies in need of a single source for clinical research

RoACTEMRA, in combination with methotrexate (MTX), is indicated for the treatment of adult patients with moderate to severe rheumatoid arthritis (RA) who have either responded inadequately to, or